产品
编 号：F745405
分子式：C22H19ClN4O3
分子量：422.86
分子式：C22H19ClN4O3
分子量：422.86
产品类型
规格
价格
是否有货
10mM*1mL in DMSO
询价
询价
5mg
询价
询价
10mg
询价
询价
25mg
询价
询价
50mg
询价
询价
结构图
CAS No: 146033-03-6
产品详情
生物活性：
SC 51089 free base is a selective antagonist of prostaglandin E2 EP1 receptor, with Kis of 1.3, 11.2, 17.5, and 61.1 μM for EP1, TP, EP3, and FP receptors, respectively. SC 51089 free base exhibits neuroprotective activity.
体内研究：
SC 51089 free base (40 μg/kg; infused i.p. for 28 d) 改善 HD 小鼠运动协调和平衡功能障碍，并挽救长期记忆缺陷。Animal Model:R6/1 mouse model of Huntington's disease (HD), from 13 to 18 weeks of age
Dosage:40 μg/kg/day
Administration:Infused i.p. at a rate of 0.11 μL/h during 28 days by osmotic mini-pump system
Result:Ameliorated motor coordination and balance dysfunction.Rescued long-term memory deficit.Improved the expression of specific synaptic markers.Reduced the number of huntingtin nuclear inclusions in the striatum and hippocampus.
体外研究：
SC 51089 free base (5 μM; 24 h) 减弱前列腺素 E2 (PGE2) 诱导的暴露于 t-BuOOH 的神经元细胞死亡。
SC 51089 free base is a selective antagonist of prostaglandin E2 EP1 receptor, with Kis of 1.3, 11.2, 17.5, and 61.1 μM for EP1, TP, EP3, and FP receptors, respectively. SC 51089 free base exhibits neuroprotective activity.
体内研究：
SC 51089 free base (40 μg/kg; infused i.p. for 28 d) 改善 HD 小鼠运动协调和平衡功能障碍，并挽救长期记忆缺陷。Animal Model:R6/1 mouse model of Huntington's disease (HD), from 13 to 18 weeks of age
Dosage:40 μg/kg/day
Administration:Infused i.p. at a rate of 0.11 μL/h during 28 days by osmotic mini-pump system
Result:Ameliorated motor coordination and balance dysfunction.Rescued long-term memory deficit.Improved the expression of specific synaptic markers.Reduced the number of huntingtin nuclear inclusions in the striatum and hippocampus.
体外研究：
SC 51089 free base (5 μM; 24 h) 减弱前列腺素 E2 (PGE2) 诱导的暴露于 t-BuOOH 的神经元细胞死亡。
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备